Positions

Overview

  • Dr. deShazo sees patients with a variety of solid tumors and is especially interested in lung and genitourinary malignancies. She has taught medical students Introduction to Clinical Medicine for more than 5 years and was recently selected as one of ten faculty designated as Core Clinical Faculty for the Department of Internal Medicine Residency training program.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Patient Demographics and Referral Patterns for [F-18]Fluciclovine-PET Imaging at a Tertiary Academic Medical CenterJournal of the American College of Radiology.  16:315-320. 2019
    2017 Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancerLung Cancer.  106:125-130. 2017
    2015 Effect of African-American Race on Tumor Recurrence after Radical Cystectomy for Urothelial Carcinoma of the BladderClinical Genitourinary Cancer.  13:469-475. 2015
    2014 Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapyUrologic Oncology: Seminars and Original Investigations.  32:501-508. 2014
    2013 Erratum to "Management of squamous cell carcinoma of the head and neck in the elderly: Review and recommendations" [J. Geriatr. Oncol. 3 (2012) 265-272]Journal of Geriatric Oncology.  4:98. 2013
    2012 Management of squamous cell carcinoma of the head and neck in the elderly: Review and recommendationsJournal of Geriatric Oncology.  3:265-272. 2012
    2012 Senior adult oncology: Clinical practice guidelines in oncology 2012
    2012 Treatment of non-small cell lung cancer in the older patient 2012
    2009 Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: Effect on chemotherapy toxicity and efficacyCancer Chemotherapy and Pharmacology.  63:731-743. 2009

    Principal Investigator On

  • Private Grant  awarded by CELLDEX THERAPEUTICS, INC. 2017 - 2021
  • Private Grant  awarded by AMGEN, INC. 2018 - 2020
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2017 - 2020
  • Investigator On

  • SWOG Purchase Services Agreement  awarded by Oregon Health & Science University 2020 - 2025
  • Private Grant  awarded by ARCUS BIOSCIENCES INC 2020 - 2025
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2020 - 2025
  • Private Grant  awarded by JOUNCE THERAPEUTICS, INC 2020 - 2025
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2019 - 2024
  • Private Grant  awarded by QED THERAPEUTICS INC 2020 - 2024
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2020 - 2024
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2020 - 2024
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2019 - 2024
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2019 - 2024
  • Private Grant  awarded by CLOVIS ONCOLOGY 2017 - 2022
  • Private Grant  awarded by CLOVIS ONCOLOGY 2017 - 2022
  • UAB 1661: Randomized Phase II Trial Comparing Sequential First-Line Sunitinib and Second-Line Avelumab Versus First-Line Avelumab and Second-Line Sunitinib for Metastatic Renal Cell Carcinoma: SUAVE Trial  awarded by HOOSIER CANCER RESEARCH NETWORK 2017 - 2022
  • UAB 1395 - Randomized Phase II Screening Trial of Enzalutamide/MDV-3100 and LHRH Analogue vs Combined Androgen Deprivation (LHRH Analogue + Bicalutamide) in Metastatic Hormone Sensitive Prostate Cancer  awarded by KARMANOS CANCER CENTER 2019 - 2021
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2017 - 2021
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2016 - 2021
  • Private Grant  awarded by MEDIVATION, INC 2019 - 2021
  • Private Grant  awarded by INNOCRIN PHARMACEUTICALS, INC. 2016 - 2020
  • Private Grant  awarded by ACERTA PHARMA B.V. 2017 - 2020
  • UAB 1764:The Targeted Agent and Profiling Utilization Registry (TAPUR) Study  awarded by American Society of Clinical Oncology 2017 - 2020
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2017 - 2020
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2017 - 2020
  • Alliance for Clinical Trials in Oncology Payment Agreement  awarded by MAYO CLINIC 2017 - 2020
  • Private Grant  awarded by ASTRAZENECA AB 2018 - 2020
  • Private Grant  awarded by CALITHERA BIOSCIENCES INC 2019 - 2020
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2015 - 2020
  • Private Grant  awarded by Bayer HealthCare 2017 - 2020
  • ECOG-ACRIN Purchase Service Agreement  awarded by Eastern Cooperative Oncology Group 2014 - 2020
  • Private Grant  awarded by MEDIVATION, INC 2015 - 2020
  • Southwest Oncology Group Purchase Service Agreement  awarded by Oregon Health & Science University 2015 - 2020
  • Private Grant  awarded by MERCK & COMPANY, INC. 2017 - 2019
  • Private Grant  awarded by MedImmune 2015 - 2019
  • Private Grant  awarded by PROSTATE CANCER CLINICAL TRIALS CONSORTIUM, LLC 2017 - 2019
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2013 - 2019
  • UAB 1395: Randomized Phase II Screening Trial of Enzalutamide/MDV-3100 and LHRH Analogue vs. Combined Androgen Deprivation (LHRH Analogue + Bicalutamide) in Metastatic Hormone Sensitive Prostate Cancer  awarded by KARMANOS CANCER CENTER 2014 - 2019
  • Biomarkers for Detection of Renal Cell Carcinoma  awarded by American Cancer Society, Inc. 2017 - 2019
  • UAB 1527 – A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer  awarded by Johns Hopkins University 2017 - 2019
  • Private Grant  awarded by EXELIXIS, INC. 2014 - 2019
  • Private Grant  awarded by STEM CENTRX 2014 - 2019
  • UAB 1360: Immune Modulation by Addition of Oral Lenalidomide to Intravesical BCG (Bacille Calmette-Guerrin) for Therapy of Non-Muscle-Invasive Transitional Cell Bladder Cancer  awarded by H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE 2014 - 2019
  • Private Grant  awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW 2018 - 2019
  • Private Grant  awarded by ALTOR BIOSCIENCE CORPORATION 2017 - 2018
  • Private Grant  awarded by STEM CENTRX 2016 - 2018
  • UAB 1311: A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination with OGX-427 in Patients with Relapsed or Refractory Metastatic Urothelial Carcinoma after Receiving a Platinum-Containing Regimen  awarded by HOOSIER ONCOLOGY GROUP 2013 - 2018
  • Private Grant  awarded by MEDIVATION, INC 2017 - 2018
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2015 - 2018
  • Private Grant  awarded by REXAHN PHARMACEUTICALS, INC. 2016 - 2018
  • Private Grant  awarded by MIRATI THERAPEUTICS, INC. 2016 - 2018
  • Private Grant  awarded by Bayer HealthCare 2015 - 2018
  • Private Grant  awarded by BELLICUM PHARMA 2013 - 2018
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2015 - 2018
  • Phase II Trial of Everolimus or Everolimus Plus Paclitaxel as First-line Therapy in Cisplatin-Ineligible Patients with Advanced Urothelial Carcinoma  awarded by HOOSIER ONCOLOGY GROUP 2013 - 2018
  • Private Grant  awarded by ONYX PHARMACEUTICALS, INC. 2014 - 2018
  • Private Grant  awarded by AGENSYS 2014 - 2018
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2015 - 2017
  • Private Grant  awarded by INNOCRIN PHARMACEUTICALS, INC. 2015 - 2017
  • Private Grant  awarded by ACERTA PHARMA B.V. 2015 - 2017
  • A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer: The TRANSFORMER Trial (Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance)  awarded by Johns Hopkins University 2015 - 2017
  • Private Grant  awarded by HEAT BIOLOGICS 2015 - 2017
  • Private Grant  awarded by REXAHN PHARMACEUTICALS, INC. 2016 - 2017
  • Private Grant  awarded by BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2015 - 2017
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2014 - 2017
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2016 - 2017
  • Private Grant  awarded by CLOVIS ONCOLOGY 2015 - 2017
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2016 - 2017
  • Private Grant  awarded by ASTRAZENECA AB 2014 - 2017
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2017
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2013 - 2017
  • Private Grant  awarded by CELLDEX THERAPEUTICS, INC. 2016 - 2017
  • Private Grant  awarded by ALTOR BIOSCIENCE CORPORATION 2013 - 2017
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2013 - 2017
  • LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2012 - 2016
  • Private Grant  awarded by ALPHA ONCOLOGY, INC 2013 - 2016
  • Private Grant  awarded by MEDIVATION, INC 2014 - 2016
  • Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus for Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors  awarded by HOOSIER ONCOLOGY GROUP 2013 - 2016
  • Private Grant  awarded by Sanofi US Services Inc 2011 - 2016
  • Private Grant  awarded by MIRATI THERAPEUTICS, INC. 2014 - 2016
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2015 - 2016
  • Private Grant  awarded by THRESHOLD PHARMACEUTICALS, INC. 2014 - 2016
  • Private Grant  awarded by EMD SERONO 2015
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP 2015
  • Private Grant  awarded by Pfizer Pharmaceuticals 2011 - 2015
  • Private Grant  awarded by Sanofi US Services Inc 2013 - 2015
  • Private Grant  awarded by SEATTLE GENETICS, INC. 2011 - 2015
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2015
  • Private Grant  awarded by Genentech 2008 - 2015
  • Private Grant  awarded by MEDIVATION, INC 2012 - 2015
  • Private Grant  awarded by ELI LILLY AND COMPANY 2013 - 2015
  • Private Grant  awarded by ELI LILLY AND COMPANY 2012 - 2015
  • Private Grant  awarded by ARAGON PHARMACEUTICALS 2013 - 2015
  • Private Grant  awarded by EISAI, INC. 2013 - 2014
  • Private Grant  awarded by GlaxoSmithKline 2007 - 2014
  • Private Grant  awarded by TRACON PHARMACEUTICALS, INC. 2011 - 2014
  • Private Grant  awarded by GlaxoSmithKline 2010 - 2013
  • Private Grant  awarded by MERRIMACK PHARMACEUTICALS, INC. 2012 - 2013
  • Education And Training

  • Doctor of Medicine in Internal Medicine Residency Program, University of Alabama at Birmingham 2000
  • UAB Hospital, Internship 2001
  • UAB Hospital, Residency 2003
  • UAB Hospital, Postdoctoral Fellowship 2006
  • Full Name

  • Mollie Deshazo